Suivre
Valerio De Stefano
Valerio De Stefano
Full Professor of Hematology, Catholic University, Italy
Adresse e-mail validée de unicatt.it
Titre
Citée par
Citée par
Année
Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trial
A Palumbo, S Bringhen, T Caravita, E Merla, V Capparella, V Callea, ...
The Lancet 367 (9513), 825-831, 2006
10492006
Cardiovascular events and intensity of treatment in polycythemia vera
R Marchioli, G Finazzi, G Specchia, R Cacciola, R Cavazzina, D Cilloni, ...
New England Journal of Medicine 368 (1), 22-33, 2013
9282013
Inherited thrombophilia: pathogenesis, clinical syndromes, and management
V De Stefano, G Finazzi, PM Mannucci
BLOOD-NEW YORK- 87, 3531-3544, 1996
7361996
The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation
V De Stefano, I Martinelli, PM Mannucci, K Paciaroni, P Chiusolo, ...
New England Journal of Medicine 341 (11), 801-806, 1999
6861999
Development and validation of an International Prognostic Score of thrombosis in World Health Organization–essential thrombocythemia (IPSET-thrombosis)
T Barbui, G Finazzi, A Carobbio, J Thiele, F Passamonti, E Rumi, ...
Blood, The Journal of the American Society of Hematology 120 (26), 5128-5133, 2012
6522012
Clinical profile of homozygous JAK2 617V>F mutation in patients with polycythemia vera or essential thrombocythemia
AM Vannucchi, E Antonioli, P Guglielmelli, A Rambaldi, G Barosi, ...
Blood, The Journal of the American Society of Hematology 110 (3), 840-846, 2007
6322007
Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: a study of 150 families
I Martinelli, PM Mannucci, V De Stefano, E Taioli, V Rossi, F Crosti, ...
Blood, The Journal of the American Society of Hematology 92 (7), 2353-2358, 1998
5931998
Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four-year prospective study from the Italian Registry
G Finazzi, V Brancaccio, M Moia, N Ciavarella, MG Mazzucconi, ...
The American journal of medicine 100 (5), 530-536, 1996
5601996
Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism
J Emmerich, FR Rosendaal, M Cattaneo, M Margaglione, V De Stefano, ...
Thrombosis and haemostasis 86 (09), 809-816, 2001
5322001
Leukocytosis as a major thrombotic risk factor in patients with polycythemia vera
R Landolfi, L Di Gennaro, T Barbui, V De Stefano, G Finazzi, RM Marfisi, ...
Blood 109 (6), 2446-2452, 2007
5262007
Incidence of venous thromboembolism in families with inherited thrombophilia
P Simioni, BJ Sanson, P Prandoni, D Tormene, PW Friederich, B Girolami, ...
Thrombosis and haemostasis 81 (02), 198-202, 1999
4471999
Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments
V De Stefano, T Za, E Rossi, AM Vannucchi, M Ruggeri, E Elli, C Micò, ...
haematologica 93 (3), 372-380, 2008
3942008
Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with …
M Cavo, L Pantani, MT Petrucci, F Patriarca, E Zamagni, D Donnarumma, ...
Blood, The Journal of the American Society of Hematology 120 (1), 9-19, 2012
382*2012
Prothrombin G20210A mutant genotype is a risk factor for cerebrovascular ischemic disease in young patients
V De Stefano, P Chiusolo, K Paciaroni, I Casorelli, E Rossi, M Molinari, ...
Blood, The Journal of the American Society of Hematology 91 (10), 3562-3565, 1998
3581998
Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia
F Zaja, M Baccarani, P Mazza, M Bocchia, L Gugliotta, A Zaccaria, ...
Blood, The Journal of the American Society of Hematology 115 (14), 2755-2762, 2010
3292010
A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis
F Passamonti, T Giorgino, B Mora, P Guglielmelli, E Rumi, M Maffioli, ...
Leukemia 31 (12), 2726-2731, 2017
3082017
Case-control study of the frequency of thrombophilic disorders in couples with late foetal loss and no thrombotic antecedent
JC Gris, I Quéré, F Monpeyrou, E Mercier, S Ripart-Neveu, ML Tailland, ...
Thrombosis and haemostasis 81 (06), 891-899, 1999
3011999
Epidemiology of factor V Leiden: clinical implications
V de Stefano, P Chiusolo, K Paciaroni, G Leone
Seminars in thrombosis and hemostasis 24 (04), 367-379, 1998
2821998
Screening for inherited thrombophilia: indications and therapeutic implications
V De Stefano, E Rossi, K Paciaroni, G Leone
haematologica 87 (10), 1095-1108, 2002
2802002
The risk of thrombosis in patients with acute leukemia: occurrence of thrombosis at diagnosis and during treatment
V De Stefano, F Sora, E Rossi, P Chiusolo, L Laurenti, L Fianchi, G Zini, ...
Journal of Thrombosis and Haemostasis 3 (9), 1985-1992, 2005
2752005
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20